Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Lins

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1991
Long-term tolerance of perindopril in hypertensive patients with impaired renal functionM Dratwa, J Sennesael, F Taillard, et al.
International Journal of Clinical Practice|June 26, 2007
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertensionJ Nussberger, A H Gradman, R E Schmieder, et al.
The International Journal of Artificial Organs|October 1, 1989
Red blood cell function and beta 2 microglobulin kinetics during cuprophan hemodialysis: a hypothesisR L Lins, P Zachée, R Daelemans, et al.
ASAIO Transactions|July 1, 1991
Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparinM T Nurmohamed, J ten Cate, P Stevens, et al.
Clinical Nephrology|February 8, 2000
Prognostic value of a new scoring system for hospital mortality in acute renal failureR L Lins, M Elseviers, R Daelemans, et al.
Clinical Nephrology|July 1, 1997
Importance of volume factors in dialysis related hypertensionR L Lins, M Elseviers, P Rogiers, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 26, 1998
Single dose pharmacokinetics of manidipine in hepatic impaired patients and healthy controlsX Deroubaix, R L Lins, S Lens, et al.
Developments in Toxicology and Environmental Science|January 1, 1980
Prognosis and treatment of methanol intoxicationR L Lins, P Zachee, M Christiaens, et al.
Nephron|January 1, 1993
Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatmentP Zachée, A Ferrant, R Daelemans, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durationsE Snoeck, V Piotrovskij, P Jacqmin, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology|January 1, 1991
Long-term tolerance of perindopril in hypertensive patients with impaired renal functionM Dratwa, J Sennesael, F Taillard, et al.
International Journal of Clinical Practice|June 26, 2007
Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertensionJ Nussberger, A H Gradman, R E Schmieder, et al.
The International Journal of Artificial Organs|October 1, 1989
Red blood cell function and beta 2 microglobulin kinetics during cuprophan hemodialysis: a hypothesisR L Lins, P Zachée, R Daelemans, et al.
ASAIO Transactions|July 1, 1991
Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparinM T Nurmohamed, J ten Cate, P Stevens, et al.
Clinical Nephrology|February 8, 2000
Prognostic value of a new scoring system for hospital mortality in acute renal failureR L Lins, M Elseviers, R Daelemans, et al.
Clinical Nephrology|July 1, 1997
Importance of volume factors in dialysis related hypertensionR L Lins, M Elseviers, P Rogiers, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 26, 1998
Single dose pharmacokinetics of manidipine in hepatic impaired patients and healthy controlsX Deroubaix, R L Lins, S Lens, et al.
Developments in Toxicology and Environmental Science|January 1, 1980
Prognosis and treatment of methanol intoxicationR L Lins, P Zachee, M Christiaens, et al.
Nephron|January 1, 1993
Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatmentP Zachée, A Ferrant, R Daelemans, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durationsE Snoeck, V Piotrovskij, P Jacqmin, et al.
Pageof 6